News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
399,795 Results
Type
Article (27323)
Company Profile (62)
Press Release (372410)
Multimedia
Podcasts (25)
Webinars (7)
Section
Business (109446)
Career Advice (549)
Deals (17770)
Drug Delivery (53)
Drug Development (49861)
Employer Resources (49)
FDA (12609)
Job Trends (8767)
News (194557)
Policy (20064)
Tag
Academia (1853)
Accelerated approval (3)
Adcomms (9)
Allergies (74)
Alliances (28359)
ALS (59)
Alzheimer's disease (862)
Antibody-drug conjugate (ADC) (59)
Approvals (12673)
Artificial intelligence (177)
Autoimmune disease (10)
Automation (4)
Bankruptcy (146)
Best Places to Work (7156)
BIOSECURE Act (6)
Biosimilars (37)
Biotechnology (41)
Bladder cancer (59)
Brain cancer (18)
Breast cancer (199)
Cancer (1479)
Cardiovascular disease (126)
Career advice (489)
Career pathing (14)
CAR-T (76)
Cell therapy (217)
Cervical cancer (13)
Clinical research (42142)
Collaboration (458)
Compensation (140)
Complete response letters (9)
COVID-19 (1566)
CRISPR (17)
C-suite (143)
Cystic fibrosis (47)
Data (1573)
Decentralized trials (2)
Denatured (17)
Depression (30)
Diabetes (184)
Diagnostics (3687)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (15)
Drug discovery (55)
Drug pricing (54)
Drug shortages (21)
Duchenne muscular dystrophy (57)
Earnings (39440)
Editorial (21)
Employer branding (6)
Employer resources (46)
Events (53920)
Executive appointments (453)
FDA (13611)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (420)
Gene editing (44)
Generative AI (12)
Gene therapy (142)
GLP-1 (430)
Government (3129)
Grass and pollen (3)
Guidances (45)
Healthcare (12571)
Huntington's disease (10)
IgA nephropathy (17)
Immunology and inflammation (48)
Indications (20)
Infectious disease (1643)
Inflammatory bowel disease (81)
Inflation Reduction Act (4)
Influenza (31)
Intellectual property (52)
Interviews (55)
IPO (7455)
IRA (19)
Job creations (1913)
Job search strategy (448)
Kidney cancer (7)
Labor market (10)
Layoffs (174)
Leadership (5)
Legal (3741)
Liver cancer (58)
Lung cancer (235)
Lymphoma (101)
Machine learning (3)
Management (17)
Manufacturing (128)
MASH (48)
Medical device (13036)
Medtech (13039)
Mergers & acquisitions (10609)
Metabolic disorders (451)
Multiple sclerosis (54)
NASH (12)
Neurodegenerative disease (54)
Neuropsychiatric disorders (10)
Neuroscience (1208)
NextGen: Class of 2025 (4090)
Non-profit (2911)
Now hiring (16)
Obesity (228)
Opinion (79)
Ovarian cancer (54)
Pain (64)
Pancreatic cancer (54)
Parkinson's disease (92)
Partnered (11)
Patents (118)
Patient recruitment (87)
Peanut (37)
People (35441)
Pharmaceutical (17)
Pharmacy benefit managers (11)
Phase I (12254)
Phase II (18285)
Phase III (14814)
Pipeline (719)
Policy (63)
Postmarket research (1720)
Preclinical (4020)
Press Release (22)
Prostate cancer (78)
Psychedelics (17)
Radiopharmaceuticals (167)
Rare diseases (197)
Real estate (3054)
Recruiting (16)
Regulatory (14686)
Reports (18)
Research institute (1682)
Resumes & cover letters (69)
Rett syndrome (3)
RNA editing (2)
RSV (21)
Schizophrenia (53)
Series A (67)
Series B (49)
Service/supplier (4)
Sickle cell disease (23)
Special edition (4)
Spinal muscular atrophy (104)
Sponsored (13)
Startups (2198)
Stomach cancer (8)
Supply chain (41)
Tariffs (12)
The Weekly (8)
Vaccines (388)
Venture capitalists (13)
Weight loss (145)
Women's health (18)
Worklife (5)
Date
Last 7 days (476)
Last 30 days (1391)
Last 365 days (19109)
2025 (6139)
2024 (20669)
2023 (23672)
2022 (32009)
2021 (34515)
2020 (33637)
2019 (29687)
2018 (22742)
2017 (19881)
2016 (19075)
2015 (22285)
2014 (16816)
2013 (13858)
2012 (15047)
2011 (15403)
2010 (13876)
Location
Africa (381)
Alabama (19)
Alaska (2)
Arizona (123)
Arkansas (10)
Asia (25303)
Australia (4109)
California (3167)
Canada (1258)
China (380)
Colorado (165)
Connecticut (174)
Delaware (116)
Europe (50442)
Florida (564)
Georgia (134)
Idaho (36)
Illinois (373)
India (15)
Indiana (224)
Iowa (4)
Japan (122)
Kansas (79)
Kentucky (13)
Louisiana (7)
Maine (29)
Maryland (644)
Massachusetts (2221)
Michigan (114)
Minnesota (298)
Mississippi (2)
Missouri (54)
Montana (19)
Nebraska (18)
Nevada (33)
New Hampshire (60)
New Jersey (1154)
New Mexico (9)
New York (996)
North Carolina (573)
North Dakota (9)
Northern California (1386)
Ohio (136)
Oklahoma (3)
Oregon (23)
Pennsylvania (850)
Puerto Rico (10)
Rhode Island (24)
South America (541)
South Carolina (21)
Southern California (1199)
Tennessee (80)
Texas (554)
United States (13264)
Utah (121)
Virginia (83)
Washington D.C. (43)
Washington State (247)
West Virginia (3)
Wisconsin (43)
399,795 Results for "heraeus medical components".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP
March 6, 2025
·
5 min read
Johnson Matthey signs agreement to sell its Medical Device Components business for US$700m
Johnson Matthey Plc (JM) announces that it has signed a definitive agreement to sell 100% of its Medical Device Components business (MDC) to Montagu Private Equity (Montagu) for cash consideration of US$700 million (£550 million) on a cash free debt free basis.
March 20, 2024
·
4 min read
Press Releases
VIVUS Announces Enrollment of First Patient in Phase 2 Clinical Trial Assessing Ethanol-Free Carmustine as a Component of High-Dose Chemotherapy Prior to Transplant in Patients with Hodgkin or Non-Hodgkin Lymphoma
April 14, 2025
·
6 min read
Immutep successfully completes institutional placement and institutional component of entitlement offer
Immutep Limited ACN 009 237 889 is pleased to announce the successful completion of its institutional placement and the institutional component of its 1 for 16 pro rata accelerated non-renounceable entitlement offer of new fully paid ordinary shares in Immutep.
June 5, 2024
·
7 min read
Press Releases
Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human
February 7, 2025
·
6 min read
Press Releases
Enalare Therapeutics Receives Second Component of a National Institutes of Health (NIH) Grant Award to Fund the Next Human Study of ENA-001
January 30, 2025
·
4 min read
Pharm Country
Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹)
Opthea Limited announced the successful completion of the institutional component of the capital raising announced on Wednesday, 12 June 2024.
June 13, 2024
·
12 min read
BioForest
Medical Components Inc. and Truveta partner to advance care for patients living with cancer and chronic kidney disease
Medical Components, Inc. is partnering with Truveta to advance the use of real-world data to improve clinical care for patients battling cancer and kidney disease who require advanced vascular access for treatment.
September 12, 2023
·
2 min read
Press Releases
Stowers scientists uncover a critical component that helps killifish regenerate their fins
September 27, 2024
·
5 min read
Deals
Vector Laboratories Merges With Absolute Biotech, Significantly Expanding Capabilities as a Critical Component Manufacturer for Life Science Customers
Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, announced its intention to merge with Absolute Biotech, a unified company of multiple antibody-centric brands.
May 15, 2024
·
4 min read
1 of 39,980
Next
